Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Thought Field Therapy and Cognitive Therapy for Agoraphobia

This study has been completed.
Information provided by (Responsible Party):
Sorlandet Hospital HF Identifier:
First received: July 3, 2009
Last updated: April 22, 2014
Last verified: April 2014
The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Condition Intervention
Behavioral: Thought field therapy
Behavioral: Cognitive therapy
Behavioral: Wait list

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Further study details as provided by Sorlandet Hospital HF:

Primary Outcome Measures:
  • Change in agoraphobic situation scores in ADIS. [ Time Frame: Immedeately and 12 months after treatment ]

Secondary Outcome Measures:
  • Interference score in ADIS [ Time Frame: Immediately and 12 months after treatment ]
  • Mobility Inventory [ Time Frame: Immediately and 12 months after treatment ]
  • Agoraphobic Cognitions Questionnaire [ Time Frame: Immediately and 12 months after treatment ]
  • Body Sensations Questionnaire [ Time Frame: Immediately and 12 months after treatment ]
  • BDI [ Time Frame: Immediately and 12 months after treatment ]
  • BAI [ Time Frame: Immediately and 12 months after treatment ]
  • WHOQOL-BREF [ Time Frame: Immediately and 12 months after treatment ]
  • SF-36 [ Time Frame: Immediately and 12 months after treatment ]
  • Safety Seeking Behaviours Questionnaire. [ Time Frame: Immediately and 12 months after treatment ]
  • Panic scale [ Time Frame: Immediately and 12 months after treatment ]

Enrollment: 72
Study Start Date: October 2006
Study Completion Date: November 2010
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Thought field therapy
24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy.
Behavioral: Thought field therapy
5 sessions with Thought field therapy
Other Name: TFT
Active Comparator: Cognitive therapy
Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model.
Behavioral: Cognitive therapy
12 sessions of Cognitive therapy
Other Name: CBT
Wait list
24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy.
Behavioral: Wait list
3 months waiting, then randomized to either thought field therapy or cognitive therapy
Other Name: WL

Detailed Description:

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients ages 18 years or older,
  • Patients with agoraphobia,
  • Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
  • Patients who give a written consent to participate.

Exclusion Criteria:

  • Psychosis (past or present),
  • Drug abuse or dependency,
  • Moderate or high score on suicidal behaviour on the M.I.N.I.,
  • Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00932919

Sorlandet Hospital
Arendal, Norway, 4809
Sponsors and Collaborators
Sorlandet Hospital HF
Principal Investigator: Audun C Irgens, MD Sorlandet Hospital HF, Norway
  More Information

Responsible Party: Sorlandet Hospital HF Identifier: NCT00932919     History of Changes
Other Study ID Numbers: SSHF-70343-AUIR-2
Study First Received: July 3, 2009
Last Updated: April 22, 2014

Keywords provided by Sorlandet Hospital HF:
Cognitive therapy
Thought field therapy
Psychotherapy research

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders processed this record on April 28, 2017